Bharat Parenterals Ltd vs Zota Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bharat Parenterals Ltd is ₹ 1285 as of 06 May 15:30 . The P/E Ratio of Bharat Parenterals Ltd changed from 9.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Zota Health Care Ltd changed from 84.1 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Bharat Parenterals Ltd changed from ₹ 192 crore on March 2021 to ₹ 680.55 crore on March 2025 . This represents a CAGR of 28.80% over 5 yearsThe Market Cap of Zota Health Care Ltd changed from ₹ 340.16 crore on March 2021 to ₹ 2306 crore on March 2025 . This represents a CAGR of 46.64% over 5 years The revenue of Bharat Parenterals Ltd for the Dec '25 is ₹ 66.52 crore as compare to the Sep '25 revenue of ₹ 68.15 crore. This represent the decline of -2.39% The revenue of Zota Health Care Ltd for the Dec '25 is ₹ 144.67 crore as compare to the Sep '25 revenue of ₹ 130.58 crore. This represent the growth of 10.79% The ebitda of Bharat Parenterals Ltd for the Dec '25 is ₹ 3.07 crore as compare to the Sep '25 ebitda of ₹ 4.35 crore. This represent the decline of -29.43% The ebitda of Zota Health Care Ltd for the Dec '25 is ₹ 1.28 crore as compare to the Sep '25 ebitda of ₹ 7.96 crore. This represent the decline of -83.92% The net profit of Bharat Parenterals Ltd changed from ₹ -8.84 crore to ₹ -9.67 crore over 7 quarters. This represents a CAGR of 5.26% The net profit of Zota Health Care Ltd changed from ₹ -12.72 crore to ₹ -29.64 crore over 7 quarters. This represents a CAGR of 62.16% The Dividend Payout of Bharat Parenterals Ltd changed from 1.78 % on March 2023 to 2.6 % on March 2025 . This represents a CAGR of 13.46% over 3 yearsThe Dividend Payout of Zota Health Care Ltd changed from -1535 % on March 2021 to 33.23 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Bharat Parenterals Ltd

Bharat Parenterals Limited was incorporated in September, 1992 in Gujarat and promoted by Ramesh Desai and Bharat Desai.
The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda.
It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company on 09 July, 2016.
Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020.
Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective from 28th June, 2022.

About Zota Health Care Ltd

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products.
The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat.
The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost. The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain.
Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business.

FAQs for the comparison of Bharat Parenterals Ltd and Zota Health Care Ltd

Which company has a larger market capitalization, Bharat Parenterals Ltd or Zota Health Care Ltd?

Market cap of Bharat Parenterals Ltd is 885 Cr while Market cap of Zota Health Care Ltd is 4,559 Cr

What are the key factors driving the stock performance of Bharat Parenterals Ltd and Zota Health Care Ltd?

The stock performance of Bharat Parenterals Ltd and Zota Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Parenterals Ltd and Zota Health Care Ltd?

As of May 6, 2026, the Bharat Parenterals Ltd stock price is INR ₹1285.0. On the other hand, Zota Health Care Ltd stock price is INR ₹1316.4.

How do dividend payouts of Bharat Parenterals Ltd and Zota Health Care Ltd compare?

To compare the dividend payouts of Bharat Parenterals Ltd and Zota Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.